Condition: Glioblastoma Multiforme, Adult · Glioblastoma or Gliosarcoma · Glioblastoma, Adult · Sponsor: Sied Kebir
The study aims to investigate the prognostic significance of olfactory function in patients with glioblastoma. We are examining olfactory function at various points during therapy and correlating the results with survival data. In addition, neurocognitive tests will be carried out to correlate the results of olfactory function with the patient's cognitive abilities. Investigations into the quality of life and psychological condition of the patients are also performed. In addition to the cohort of glioblastoma patients, there is a control cohort without tumor disease in which the olfactory testing is also carried out in order to have a comparison.
This description comes directly from the study's public registry record.
Christoph Oster, Dr. med. · +49201-723-82598 · christoph.oster@uk-essen.de
Sied Kebir, PD Dr. med. · +49201-723-83133 · sied.kebir@uk-essen.de
Always discuss trial participation with your own doctor first.
| University Hospital Essen, Department of Neurology, Division of Clinical Neuro-Oncology | Essen, Germany | Recruiting |
| Department of Neurosurgery | Münster, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06954636